Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,010
-
Total 13F shares
-
9,135,304
-
Share change
-
-47,626
-
Total reported value
-
$141,452,290
-
Price per share
-
$15.51
-
Number of holders
-
82
-
Value change
-
-$612,075
-
Number of buys
-
45
-
Number of sells
-
25
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q3 2025
As of 30 Sep 2025,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,135,304 shares.
The largest 10 holders included
Saba Capital Management, L.P., MORGAN STANLEY, Penserra Capital Management LLC, RAYMOND JAMES FINANCIAL INC, NEEDHAM INVESTMENT MANAGEMENT LLC, LPL Financial LLC, FLAGSHIP HARBOR ADVISORS, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, Karpus Management, Inc., and Allspring Global Investments Holdings, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.